Elisa Redl
Sola Diagnostics GmbH, Universität Innsbruck, University of Vienna, Labor DrDr. Mustafa
Research areas: Biochemistry, Genetics and Molecular Biology · Molecular Biology · Epigenetics and DNA Methylation · Cervical Cancer and HPV Research · Endometrial and Cervical Cancer Treatments
0000-0001-6540-8443
About
I'm a molecular biologist with a research focus and expertise on DNA methylation and epigenetics in cancer research. I'm currently working as a lab manager at the Eutops Institute at the University of Innsbruck, where we develop DNA methylation-specific tests for the early detection and prediction of women's cancer. Furthermore, I'm Head of Analytical Development at Sola Diagnostics GmbH, where we develop and market minimally invasive epigenetic diagnostic tools, such as the WID®-easy and WID®-can Tests.
Employment
-
Sola Diagnostics GmbH Head of Analytical Development2024 - Present
-
University of Innsbruck Laboratory Manager2021 - Present
-
Labor DrDr. Mustafa Molecular Biologist2020 - 2021
-
Medical University of Vienna PhD student2015 - 2019
Education
- 2007 - 2011
Projects & Funding
Projects & funding information is unavailable.
Publications (20)
- The cervico‐vaginal DNA methylation WID‐qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer Save
- Short-term hormonal modulation with mifepristone does not induce oncogenic changes in the endometrium of BRCA1/2 pathogenic variant carriers Save
- Longitudinal multi-omic evaluation of biomarkers of health and ageing over smoking cessation intervention Save
- Systemic multi-omic remodelling underlies health benefits of intermittent fasting Save
- Multi-modal atlas of lifestyle interventions reveals malleability of ageing-linked molecular features Save
- Epigenetic signatures in surrogate tissues are able to assess cancer risk and indicate the efficacy of preventive measures Save
- Functionally enriched epigenetic clocks reveal tissue-specific discordant aging patterns in individuals with cancer Save
- Performance of the WID‐qEC test to detect uterine cancers in black women with abnormal uterine bleeding: A prospective observational cohort study in Ghana Save
- Technical and biological sources of unreliability of Infinium probes on Illumina methylation microarrays Save
- High performance of the DNA methylation‐based WID‐qEC test for detecting uterine cancers independent of sampling modalities Save
- Cervical cancer screening using DNA methylation triage in a real-world population Save
- A validated HPLC-MS/MS method for the quantification of systemic mifepristone after subcutaneous application in mice Save
- Performance of the WID-qEC test versus sonography to detect uterine cancers in women with abnormal uterine bleeding (EPI-SURE): a prospective, consecutive observational cohort study in the UK Save
- STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway Save
- The <scp>WID‐qEC</scp> test: Performance in a hospital‐based cohort and feasibility to detect endometrial and cervical cancers Save
- DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test Save
- Identification of tumor tissue-derived DNA methylation biomarkers for the detection and therapy response evaluation of metastatic castration resistant prostate cancer in liquid biopsies Save
- A Simple Cervicovaginal Epigenetic Test for Screening and Rapid Triage of Women With Suspected Endometrial Cancer: Validation in Several Cohort and Case/Control Sets Save
- Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis. Save
- Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling. Save